Effectiveness and Safety in Maternal and Neonatal Outcomes in Water Birth.
Launched by FUNDACIÓN PARA EL FOMENTO DE LA INVESTIGACIÓN SANITARIA Y BIOMÉDICA DE LA COMUNITAT VALENCIANA · May 20, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
At present there is controversy and doubts about the increase in the number of interventions involving the use of epidural analgesia(EA), but there is also controversy about the safety of the use of water, especially in those processes where the birth ends in water, called Waterbirth (WB). Given the popularity of these two methods, the aim is to study and compare the maternal and neonatal outcomes derived from the use of both methods in order to provide greater knowledge to women in their decision making.
For this purpose, a prospective observational study will be carried out in low-risk p...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women at term with normal pregnancy without the presence of maternal and neonatal risk factors that preclude the use of water and epidural analgesia at the time of admission to the delivery room.
- • Pregnant women who are 18 years of age or older or who will turn 18 in the year of delivery.
- • Have the psychic and cognitive capacity to make decisions.
- • Desire to be part of the study and signature of informed consent to participate in the study.
- Exclusion Criteria:
- • .Presence of any maternal or fetal risk factor that precludes the choice of water or epidural analgesia at the time of admission to the dilation room in active labor.
- • Under 17 years of age or under 18 years of age in the year of delivery.
- • .Ideomatic barrier that makes it impossible for the patient to understand the study and to agree to the informed consent, .Unwillingness to participate or failure to sign the informed consent form.
Trial Officials
Soledad Carregui Vilar, Midwife
Principal Investigator
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
About Fundación Para El Fomento De La Investigación Sanitaria Y Biomédica De La Comunitat Valenciana
The Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana is a prominent clinical trial sponsor dedicated to advancing health research in the Valencian Community. By fostering collaboration between healthcare institutions, academic entities, and industry partners, the foundation aims to enhance biomedical innovation and improve public health outcomes. With a focus on prioritizing patient welfare and ethical research practices, it actively supports the development of cutting-edge therapies and medical solutions through rigorous clinical trials and research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vila Real, Castellon, Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0